nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—hypertension—adrenal gland cancer	0.711	1	CtDrD
Candesartan—ABCB1—adrenal gland cancer	0.28	1	CbGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—REN—adrenal gland cancer	0.00108	0.134	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.000531	0.0659	CbGpPWpGaD
Candesartan—AGTR1—Arf6 signaling events—TSHR—adrenal gland cancer	0.000516	0.0641	CbGpPWpGaD
Candesartan—AGTR1—Arf6 trafficking events—TSHR—adrenal gland cancer	0.000407	0.0506	CbGpPWpGaD
Candesartan—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000293	0.0364	CbGpPWpGaD
Candesartan—Telmisartan—ABCB1—adrenal gland cancer	0.000287	0.658	CrCbGaD
Candesartan—AGTR1—Peptide GPCRs—TSHR—adrenal gland cancer	0.000283	0.0352	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.000253	0.0314	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000226	0.0281	CbGpPWpGaD
Candesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.000175	0.0217	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000167	0.0208	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—ABCB1—adrenal gland cancer	0.000153	0.0191	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000151	0.0188	CbGpPWpGaD
Candesartan—Losartan—ABCB1—adrenal gland cancer	0.000149	0.342	CrCbGaD
Candesartan—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.000137	0.017	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000135	0.0168	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000127	0.0158	CbGpPWpGaD
Candesartan—AGTR1—Arf6 signaling events—EGFR—adrenal gland cancer	0.000114	0.0142	CbGpPWpGaD
Candesartan—AGTR1—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.000114	0.0141	CbGpPWpGaD
Candesartan—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.000114	0.0141	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0001	0.0125	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	9.51e-05	0.0118	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	8.94e-05	0.0111	CbGpPWpGaD
Candesartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	8.67e-05	0.0108	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	8.5e-05	0.0106	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	8.3e-05	0.0103	CbGpPWpGaD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	8.26e-05	0.0103	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—GNRH1—adrenal gland cancer	7.64e-05	0.00949	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	7.2e-05	0.00895	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—TSHR—adrenal gland cancer	6.81e-05	0.00846	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GNRHR—adrenal gland cancer	6.54e-05	0.00813	CbGpPWpGaD
Candesartan—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	6.32e-05	0.00785	CbGpPWpGaD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.55e-05	0.00689	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	5.53e-05	0.00687	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—POMC—adrenal gland cancer	5.23e-05	0.0065	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	5.22e-05	0.00648	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	5.14e-05	0.00638	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SDHB—adrenal gland cancer	4.68e-05	0.00581	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	4.45e-05	0.00553	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	4.42e-05	0.00549	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.32e-05	0.00536	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	4.08e-05	0.00507	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	4.02e-05	0.00499	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—GNAS—adrenal gland cancer	3.96e-05	0.00492	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	3.92e-05	0.00487	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GNRHR—adrenal gland cancer	3.86e-05	0.0048	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	3.85e-05	0.00478	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.6e-05	0.00447	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.59e-05	0.00446	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.58e-05	0.00445	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.5e-05	0.00435	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TSHR—adrenal gland cancer	3.49e-05	0.00434	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	3.38e-05	0.0042	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	3.32e-05	0.00413	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	3.17e-05	0.00394	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—SDHD—adrenal gland cancer	3.01e-05	0.00375	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—RRM1—adrenal gland cancer	3.01e-05	0.00375	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—POMC—adrenal gland cancer	2.95e-05	0.00366	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	2.92e-05	0.00362	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.84e-05	0.00353	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.67e-05	0.00332	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—POMC—adrenal gland cancer	2.67e-05	0.00331	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SDHB—adrenal gland cancer	2.64e-05	0.00327	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	2.51e-05	0.00311	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	2.34e-05	0.00291	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GNRH1—adrenal gland cancer	2.31e-05	0.00288	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MED12—adrenal gland cancer	2.25e-05	0.00279	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	2.24e-05	0.00278	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CDC42—adrenal gland cancer	2.13e-05	0.00264	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPRY2—adrenal gland cancer	2.12e-05	0.00263	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.07e-05	0.00258	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSHR—adrenal gland cancer	2.06e-05	0.00256	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GNAS—adrenal gland cancer	2.03e-05	0.00252	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MEN1—adrenal gland cancer	1.94e-05	0.00241	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	1.9e-05	0.00237	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.84e-05	0.00228	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDHB—adrenal gland cancer	1.7e-05	0.00211	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RRM1—adrenal gland cancer	1.7e-05	0.00211	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SDHD—adrenal gland cancer	1.7e-05	0.00211	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.65e-05	0.00206	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PRKACA—adrenal gland cancer	1.64e-05	0.00204	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	1.55e-05	0.00192	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—POMC—adrenal gland cancer	1.51e-05	0.00187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.49e-05	0.00186	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.48e-05	0.00184	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKACA—adrenal gland cancer	1.48e-05	0.00184	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDHB—adrenal gland cancer	1.39e-05	0.00172	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—POMC—adrenal gland cancer	1.37e-05	0.0017	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.34e-05	0.00166	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GNAS—adrenal gland cancer	1.33e-05	0.00165	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	0.00162	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MED12—adrenal gland cancer	1.27e-05	0.00157	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDC42—adrenal gland cancer	1.26e-05	0.00156	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.22e-05	0.00151	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF2—adrenal gland cancer	1.21e-05	0.0015	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GNAS—adrenal gland cancer	1.2e-05	0.00149	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1R—adrenal gland cancer	1.17e-05	0.00145	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.13e-05	0.00141	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.11e-05	0.00138	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RRM1—adrenal gland cancer	1.1e-05	0.00136	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDHD—adrenal gland cancer	1.1e-05	0.00136	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.09e-05	0.00135	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.09e-05	0.00135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—adrenal gland cancer	1.01e-05	0.00125	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDHD—adrenal gland cancer	9.56e-06	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RRM1—adrenal gland cancer	9.56e-06	0.00119	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PRKACA—adrenal gland cancer	9.24e-06	0.00115	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.03e-06	0.00112	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	8.99e-06	0.00112	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—POMC—adrenal gland cancer	8.95e-06	0.00111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RRM1—adrenal gland cancer	8.93e-06	0.00111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDHD—adrenal gland cancer	8.93e-06	0.00111	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BAD—adrenal gland cancer	8.77e-06	0.00109	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.62e-06	0.00107	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MED12—adrenal gland cancer	8.18e-06	0.00102	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—adrenal gland cancer	8.08e-06	0.001	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BRAF—adrenal gland cancer	7.98e-06	0.000991	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—adrenal gland cancer	7.73e-06	0.000961	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNAS—adrenal gland cancer	7.49e-06	0.00093	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—adrenal gland cancer	7.35e-06	0.000913	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.31e-06	0.000908	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.24e-06	0.000899	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—adrenal gland cancer	7.14e-06	0.000887	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MED12—adrenal gland cancer	7.12e-06	0.000885	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MED12—adrenal gland cancer	6.66e-06	0.000827	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	5.97e-06	0.000741	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.95e-06	0.000739	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.83e-06	0.000724	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.77e-06	0.000716	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PRKACA—adrenal gland cancer	5.2e-06	0.000646	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—adrenal gland cancer	5.04e-06	0.000626	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	4.86e-06	0.000603	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNAS—adrenal gland cancer	4.84e-06	0.000601	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.75e-06	0.00059	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	4.74e-06	0.000589	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—adrenal gland cancer	4.57e-06	0.000568	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNAS—adrenal gland cancer	4.21e-06	0.000523	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—adrenal gland cancer	4.02e-06	0.000499	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNAS—adrenal gland cancer	3.94e-06	0.000489	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	3.86e-06	0.00048	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—adrenal gland cancer	3.84e-06	0.000477	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—adrenal gland cancer	3.26e-06	0.000404	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—adrenal gland cancer	2.84e-06	0.000352	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—adrenal gland cancer	2.65e-06	0.000329	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	2.6e-06	0.000323	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.26e-06	0.000281	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	2.11e-06	0.000263	CbGpPWpGaD
